Abstract:AIM:To study Hepatitis B virus (HBV) infection and its association with hepatocellular carcinoma (HCC) at the miRNA level.METHODS:Three cellular models were used to investigate miRNA expression changes during HBV infection: human HepG2 hepatoblastoma cell line as a model without HBV infection; HepG2 cell line transfected with a 1.3-fold full-length HBV genome as an acute infection model; and HepG2.2.15 cell line, which is derived from HepG2 and stably transfected with a complete HBV genome, as a chronic infection model. The miRNA levels were examined using microarray technology. To explore the relationship between HBV infection and HCC genesis at the miRNA level, we downloaded from national center for biotechnology information Gene Expression Omnibus an miRNA expression dataset derived from HCC patients, most of whom are HBV carriers. We compared the miRNA expression alterations during HBV infection with those in HCC patients, by analyzing miRNA expression change profiles statistically.RESULTS:Seventy-seven and 48 miRNAs were differentially expressed during acute and chronic HBV infection, respectively. Among these miRNAs, 25 were in common, the intersection of which was significant under the hypergeometric test (P = 1.3 × 10⁻¹¹). Fourteen miRNAs were observed to change coherently in the acute and chronic infections, with one upregulated and 13 downregulated. Eleven showed inverse changes during the two phases of infection; downregulated in the acute infection and upregulated in the chronic infection. The results imply that common and specific mechanisms exist at the miRNA level during acute and chronic HBV infection. Besides, comparative analysis of the miRNA expression changes during HBV infection with those in HCC indicates that, although miRNA expression changes during HBV infection are distinct from those in HCC patients (P < 2.2 × 10⁻¹⁶), they exhibited significant correlations (P = 0.0229 for acute infection; P = 0.0084 for chronic infection). Perturbation of miRNA expression during chronic HBV infection was closer to that in HCC patients than that during acute HBV infection. This observation implies the contribution of miRNAs to HCC genesis from HBV infection. According to their patterns of differential expression in acute and chronic HBV infection, as well as in HCC, miRNAs of potential research interest could be identified, such as miR-18a/miR-18b, miR-106a, miR-221 and miR-101. For instance, the gradient expression alteration of miR-221 in the above three phases, which is downregulated in acute HBV infection, normally expressed in chronic HBV infection, and upregulated in HCC, indicates that it may be a key effector for progression of the disease.CONCLUSION:Our analysis provides insights into HBV infection and related HCC in relation to miRNAs, and reveals some candidate miRNAs for future studies.

HCV Infection Induces the Upregulation of Mir-221 in NF-κB Dependent Manner

Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells

MiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3

Hepatitis C Virus-Induced Up-Regulation of Microrna-155 Promotes Hepatocarcinogenesis by Activating Wnt Signaling.

Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis

Mir-221 Promotes Growth and Invasion of Hepatocellular Carcinoma Cells by Constitutive Activation of NFκB.

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

Hepatitis C Virus Infection Cycle-Specific MicroRNA Profiling Reveals Stage-Specific Mir-4423-3p Targets RIG-I to Facilitate Infection

Hepatitis B Virus and Hepatocellular Carcinoma at the Mirna Level.

Up-regulated MicroRNA-181a Induces Carcinogenesis in Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting E2F5

Involvement of TLR2-MyD88 in Abnormal Expression of Mir-146A in Peripheral Blood Monocytes of Patients with Chronic Hepatitis C.

Monocyte Chemoattractant Protein 1 Released from Macrophages Induced by Hepatitis C Virus Promotes Monocytes Migration

Hepatitis C Virus Core Impacts Expression of Mir122 and Mir204 Involved in Carcinogenic Progression Via Regulation of TGFBRAP1 and HOTTIP Expression

Functional Analysis of Mir-181A and Fas Involved in Hepatitis B Virus-Related Hepatocellular Carcinoma Pathogenesis.

Identification of Deregulated Mirnas and Their Targets in Hepatitis B Virus-Associated Hepatocellular Carcinoma

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.

HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1

Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma

Expression of Serum Micrornas (Mir-222, Mir-181, Mir-216) in Human Hepatocellular Carcinoma and Its Clinical Significance

Upregulation of DARS2 by HBV Promotes Hepatocarcinogenesis Through the Mir-30E-5p/mapk/nfat5 Pathway

HCV‐induced Mir146a Controls SOCS1/STAT3 and Cytokine Expression in Monocytes to Promote Regulatory T‐cell Development